The DOI matches its Crossref record; 67 of the 74 references it cites were found in a registry or an index.
Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion
Abstract
Zolmitriptan (ZT) is a well-tolerated drug in migraine treatment suffering from low bioavailability due to low amount of the drug that reaches the brain after oral and nasal delivery. Development of new nasal mucoadhesive nanoemulsion formulation for zolmitriptan may success in delivering the drug directly from the nose to the brain to achieve rapid onset of action and high drug concentration in the brain which is required for treatment of acute migraine. ZT mucoadhesive nanoemulsion were prepared and characterized for drug content, zeta potential, particle size, morphology, residence time and permeation through the nasal mucosa. The selected formula was tested in-vivo in mice for its pharmacokinetics in comparison with intravenous and nasal solution of zolmitriptan. Results showed that addition of chitosan as mucoadhesive agent in 0.3% concentration to the nanoemulsion enhanced its residence time and zetapotential with no significant effect on the globule size. All tested formulations showed higher permeability coefficients than the zolmitriptan solution through the nasal mucosa. In-vivo studies showed that the mucoadhesive nanoemulsion formulation of zolmitriptan has higher AUC 0-8 and shorter T max in the brain than the intravenous or the nasal solution. This was related to the small globule size and higher permeability of the formulation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Important differences can be found between classical macroemulsions (classical emulsions), NEs and microemulsions in droplet size range and stability characteristics [32,47].”
From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [47]
In the citing paper
“In vivo studies carried out on Sprague–Dawley rats showed that the mucoadhesive (chitosan containing) NE presents higher AUC and shorter Tmax in the brain than intravenous or the nasal solutions.”
From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [47]
In the citing paper
“The addition to the NE of chitosan as a mucoadhesive agent in 0.3% enhanced the residence time and zeta potential of the formulation with no relevant effect on the globule size.”
From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [47]
Citations
Cites
Nanoemulsions: Formation, properties and applications
Gupta, A., Eral, H. B., Hatton, T. A., & Doyle, P. S. (2016) · Soft Matter · doi:10.1039/c5sm02958a · Cited by 1,633
Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
Artursson, P., Lindmark, T., Davis, S. S., & Illum, L. (1994) · Pharmaceutical Research · doi:10.1023/a:1018967116988 · Cited by 766
Nanoparticles for direct nose-to-brain delivery of drugs
Mistry, A., Stolnik, S., & Illum, L. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.019 · Cited by 734
Intranasal Drug Delivery: How, Why and What For?
Pires, A., Fortuna, A., Alves, G., & Falcão, A. (2009) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3nc79 · Cited by 641
Pardeshi, C. V., & Belgamwar, V. S. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.790887 · Cited by 482
Intranasal nanoemulsion based brain targeting drug delivery system of risperidone
Kumar, M., Misra, A., Babbar, A. K., Mishra, A. K., Mishra, P., & Pathak, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.03.029 · Cited by 435
Nasal drug delivery: new developments and strategies
Illum, L. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02529-1 · Cited by 432
Insights into Direct Nose to Brain Delivery: Current Status and Future Perspective
Mittal, D., Ali, A., Md, S., Baboota, S., Sahni, J. K., & Ali, J. (2014) · Drug Delivery · doi:10.3109/10717544.2013.838713 · Cited by 359
Md, S., Khan, R. A., Mustafa, G., Chuttani, K., Baboota, S., Sahni, J. K., & Ali, J. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.12.007 · Cited by 307
Microemulsion formulation for enhanced absorption of poorly soluble drugs
Kawakami, K., Yoshikawa, T., Moroto, Y., Kanaoka, E., Takahashi, K. S., Nishihara, Y., & Masuda, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00049-4 · Cited by 306
Engineering of nanoemulsions for drug delivery
Sarker, D. (2005) · Current Drug Delivery · doi:10.2174/156720105774370267 · Cited by 268
Rao, J., & McClements, D. J. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf200094m · Cited by 266
Aspden, T., Mason, J. D. T., Jones, N. S., Lowe, J. S., Skaugrud, Ø., & Illum, L. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960182o · Cited by 257
Fryd, M. M., & Mason, T. G. (2012) · Annual Review of Physical Chemistry · doi:10.1146/annurev-physchem-032210-103436 · Cited by 252
In situ forming hydrogels based on chitosan for drug delivery and tissue regeneration
Liu, L., Gao, Q., Lü, X., & Zhou, H. (2016) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2016.07.001 · Cited by 234
Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting
Mahajan, H. S., Mahajan, M. S., Nerkar, P. P., & Agrawal, A. (2014) · Drug Delivery · doi:10.3109/10717544.2013.838014 · Cited by 212
Chitosan as a Lipid Binder: A Langmuir Monolayer Study of Chitosan−Lipid Interactions
Wydro, P., Krajewska, B., & Hąc-Wydro, K. (2007) · Biomacromolecules · doi:10.1021/bm700453x · Cited by 207
Choudhury, H., Gorain, B., Karmakar, S., Biswas, E., Dey, G., Barik, R., Mandal, M., & Pal, T. K. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.10.055 · Cited by 207
Pangeni, R., Sharma, S., Mustafa, G., Ali, J., & Baboota, S. (2014) · Nanotechnology · doi:10.1088/0957-4484/25/48/485102 · Cited by 192
Microemulsion formulation for enhanced absorption of poorly soluble drugs
Kawakami, K., Yoshikawa, T., Hayashi, T., Nishihara, Y., & Masuda, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00050-0 · Cited by 188
From nose to brain: understanding transport capacity and transport rate of drugs
Wu, H., Hu, K., & Jiang, X. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.10.1159 · Cited by 188
He, C., He, Z., & Gao, J. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425241003596337 · Cited by 184
Nasal sumatriptan is effective in treatment of migraine attacks in children
Ahonen, K., Hämäläinen, M. L., Rantala, H., & Hoppu, K. (2004) · Neurology · doi:10.1212/01.wnl.0000115105.05966.a7 · Cited by 183
Effectiveness of Intranasal Zolmitriptan in Acute Cluster Headache
Cittadini, E., May, A., Straube, A., Evers, S., Bussone, G., & Goadsby, P. J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.11.nct60002 · Cited by 153
Shah, B. M., Misra, M., Shishoo, C. J., & Padh, H. (2014) · Drug Delivery · doi:10.3109/10717544.2013.878857 · Cited by 136
Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers
Paudel, K. S., Hammell, D. C., Agu, R. U., Valiveti, S., & Stinchcomb, A. L. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639041003657295 · Cited by 134
Abd-Elal, R. M. A., Shamma, R. N., Rashed, H. M., & Bendas, E. R. (2016) · Drug Delivery · doi:10.1080/10717544.2016.1183721 · Cited by 131
Nanoemulsion improves the oral bioavailability of baicalin in rats: in vitro and in vivo evaluation
Zhao, L., Wei, Y.-M., Huang, Y., He, B., Zhou, Y., & Fu, J.-J. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s51578 · Cited by 129
Speed of Onset and Efficacy of Zolmitriptan Nasal Spray in the Acute Treatment of Migraine
Charlesworth, B. R., Dowson, A. J., Purdy, A., Becker, W. J., Boes-Hansen, S., & rkkil, M. F. (2003) · CNS Drugs · doi:10.2165/00023210-200317090-00005 · Cited by 125
Matsaridou, I., Barmpalexis, P., Salis, A., & Nikolakakis, I. (2012) · AAPS PharmSciTech · doi:10.1208/s12249-012-9855-7 · Cited by 118
Intranasal mucoadhesive microemulsions of zolmitriptan: Preliminary studies on brain-targeting
Vyas, T. K., Babbar, A. K., Sharma, R. K., & Misra, A. R. (2005) · Journal of drug targeting · doi:10.1080/10611860500246217 · Cited by 113
Charlton, S. T., Jones, N. S., Davis, S. S., & Illum, L. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.11.018 · Cited by 109
Quetiapine Nanoemulsion for Intranasal Drug Delivery: Evaluation of Brain-Targeting Efficiency
Boche, M., & Pokharkar, V. (2017) · AAPS PharmSciTech · doi:10.1208/s12249-016-0552-9 · Cited by 109
Role of Surfactants as Penetration Enhancer in Transdermal Drug Delivery System
Pandey, A. (2014) · Journal of Molecular Pharmaceutics & Organic Process Research · doi:10.4172/2329-9053.1000113 · Cited by 102
Pandey, Y. R., Kumar, S., Gupta, B. K., Ali, J., & Baboota, S. (2016) · Nanotechnology · doi:10.1088/0957-4484/27/2/025102 · Cited by 96
Sharma, S., Sahni, J. K., Ali, J., & Baboota, S. (2014) · Drug Delivery · doi:10.3109/10717544.2014.893382 · Cited by 87
Formulation and Evaluation of Thermosensitive Biogels for Nose to Brain Delivery of Doxepin
Naik, A. A., & Nair, H. A. (2014) · BioMed Research International · doi:10.1155/2014/847547 · Cited by 76
Brain uptake of an anti-ischemic agent by nasal administration of microparticles
Dalpiaz, A., Gavini, E., Colombo, G., Russo, P., Bortolotti, F., Ferraro, L., Tanganelli, S., Scatturin, A., Menegatti, E., & Giunchedi, P. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21335 · Cited by 75
Design and Characterization of Microemulsion Systems for Naproxen
Moghimipour, E., Salimi, A., & Eftekhari, S. (2013) · PubMed · doi:10.5681/apb.2013.011 · Cited by 74
Light-scattering investigations on dilute nonionic oil-in-water microemulsions
Warisnoicharoen, W., Lansley, A. B., & Lawrence, M. J. (2000) · AAPS PharmSci · doi:10.1208/ps020212 · Cited by 65
Nanotechnology for CNS delivery of bio-therapeutic agents
Shah, L. K., Yadav, S. K., & Amiji, M. M. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-013-0133-3 · Cited by 64
Stevens, J., Ploeger, B. A., van der Graaf, P. H., Danhof, M., & de Lange, E. C. M. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040782 · Cited by 64
Study on the Potential Toxicity of a Thymoquinone-Rich Fraction Nanoemulsion in Sprague Dawley Rats
Tubesha, Z., Imam, M. U., Mahmud, R., & Ismail, M. (2013) · Molecules · doi:10.3390/molecules18077460 · Cited by 54
Zolmitriptan Intranasal: A Review of the Pharmacokinetics and Clinical Efficacy
Goadsby, P. J., & Yates, R. (2006) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00301.x · Cited by 54
The triptan formulations: a critical evaluation
BIGAL, M. E., Bordini, C. A., Antoniazzi, A. L. D. L., & Speciali, J. G. (2003) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2003000200032 · Cited by 54
Development and characterization of evening primrose (Oenothera biennis) oil nanoemulsions
Rodrigues, R. F., Costa, I. C., Almeida, F. B., Cruz, R. A. S., Ferreira, A. M., Vilhena, J. C. E., Florentino, A. C., Carvalho, J. C. T., & Fernandes, C. P. (2015) · Revista Brasileira de Farmacognosia · doi:10.1016/j.bjp.2015.07.014 · Cited by 46
Muzykantov, V. R. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.750292 · Cited by 44
Mahmoud, H. (2013) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajpp2013.2987 · Cited by 43
Optimization of ThermoreversibleIn SituNasal Gel of Timolol Maleate
Jagdale, S. C., Shewale, N., & Kuchekar, B. S. (2016) · Scientifica · doi:10.1155/2016/6401267 · Cited by 38
Palmer, K. J., & Spencer, C. M. (1997) · CNS Drugs · doi:10.2165/00023210-199707060-00005 · Cited by 32
Basu, S., & Maity, S. (2012) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.108418 · Cited by 29
Brain targeting efficiency of Curcumin loaded mucoadhesive microemulsion through intranasal route
Mandal, S. D., Mandal, S., & Patel, J. K. (2016) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-016-0227-2 · Cited by 25
Abdel‐Bar, H. M., Abdel-Reheem, A. Y., Awad, G. A. S., & Mortada, N. D. (2013) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j30s31 · Cited by 24
Umeyor, C. E., Attama, A. A., Uronnachi, E., Kenechukwu, F. C., Nwakile, C. D., Nzekwe, I. T., Okoye, E., & Esimone, C. O. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.10.033 · Cited by 23
Raza, A., Ansari, T. M., & Niazi, S. B. (2007) · Journal of the Chinese Chemical Society · doi:10.1002/jccs.200700201 · Cited by 21
Comparison of Nanoemulsion and Aqueous Micelle Systems of Paliperidone for Intranasal Delivery
Pidaparthi, K., & Suares, D. (2016) · AAPS PharmSciTech · doi:10.1208/s12249-016-0640-x · Cited by 21
Nasal melatonin gels using pluronic PF-127 for chronobiological treatment of sleep disorder
Pisal, S. S., Reddy, P. S., Paradkar, A. R., Mahadik, K. R., & Kadam, S. S. (2004) · Cited by 13
DESIGN ZOLMITRIPTAN LIQUISOLID ORODISPERSIBLE TABLETS AND THEIR IN VITRO EVALUATION
Egla, M., & Hammid, S. N. A. A. (2016) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2017v9i1.15656 · Cited by 13
Nanoemulsion based intranasal delivery of risperidone for nose to brain targeting
Pathak, D., Prajapati, S. T., & Pathak, S. P. (2018) · American Journal of Pharmacology and Pharmacotherapeutics · Cited by 11
Functional neurotoxicity evaluation of noribogaine using video-EEG in cynomolgus monkeys
Authier, S., Accardi, M. V., Paquette, D., Pouliot, M., Arezzo, J. C., Stubbs, R. J., Gerson, R. J., Friedhoff, L. T., & Weis, H. (2016) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2016.04.012 · Cited by 10
FORMULATION AND EVALUATION OF ION-SENSITIVE IN-SITU NASAL GEL OF ZOLMITRIPTAN
Patil, P. R., Salve, V., Thorat, R., & Shahi, S. (2015) · International Journal of Pharmacy and Pharmaceutical Sciences · Cited by 8
Teリッチおよび化学量論的Bi 2 Te 3 ナノワイヤのRamanスペクトロスコピーによる指紋
Carlos, R.-F., Manzano, C. V., Romero Aldo, H., Jaime, M., Marisol, M.-G., Morais, D. L. M., & Andres, C. (2016) · Nanotechnology · Cited by 8
Development of Microemulsion for Solubility Enhancement of Poorly Water Soluble Drug Valsartan
Shahu, S. G., Wadetwar, R. N., & Dixit, G. (2013) · Cited by 7
Zolmitriptan Nasal In-situ Gel Using Sterculia Foetida Linn Gum As Natural Mucoadhesive Polymer
Upadhye, K. P. (2013) · Cited by 6
Gonjari, I., Karmarkar, A. B., & Kasture, P. V. (2009) · PubMed · Cited by 4
DESIGN AND DEVELOPMENT OF SOLID DISPERSION SYSTEM OF ZOLMITRIPTAN
Nandy, B. C., Gupta, A. K., Mittal, A., & Khan, M. Z. (2013) · Journal of Biomedical and Pharmaceutical Research · Cited by 2
Research works printed but not linked: 6
- Awari, 2013, Bio analytical hplc method development and validation of zolmitriptan in rabbit plasma, Int. J. Bio. Pharm. Res., 4, 1160
- Kolsure, 2012, Development of zolmitriptan gel for nasal administration, Asian J. Pharm. Clin. Res., 5, 88
- Meor Mohd Affandi, 2011, Development and stability evaluation of Astaxanthin nanoemulsion, Asian J. Pharm. Clin. Res., 4, 142
- Niranjan, 2015, Formulation, design and in vitro evaluation of zolmitriptan immediate release tablets using Primojel and AC-Di-Sol, J. Pharm. Sci. Res., 7, 545
- Patel, 2013, Formulation and evaluation of microemulsion based-drug delivery system for intranasal administration of olanzapine, Int. J. Biomed. Pharm. Sci., 7, 20
- Tandel, 2015, Preparation and study of efavirenz microemulsion drug delivery system for enhancement of bioavailability, Euro. J. Pharm. Med. Res., 2, 1156
Cited by
Sorted by citations
Nanoemulsions for drug delivery
Wilson, R. J., Li, Y., Yang, G., & Zhao, C. (2021) · Particuology · doi:10.1016/j.partic.2021.05.009 · Cited by 410
Nanoemulsions for “Nose-to-Brain” Drug Delivery
Bonferoni, M. C., Rossi, S., Sandri, G., Ferrari, F., Gavini, E., Rassu, G., & Giunchedi, P. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020084 · Cited by 269
Jeong, S., Jang, J.-H., & Lee, Y. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00589-5 · Cited by 289
Multiple Roles of Chitosan in Mucosal Drug Delivery: An Updated Review
Mura, P., Maestrelli, F., Cirri, M., & Mennini, N. (2022) · Marine Drugs · doi:10.3390/md20050335 · Cited by 279
Wang, Z., Xiong, G., Tsang, W. C., Schätzlein, A. G., & Uchegbu, I. F. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.258152 · Cited by 247
Metadata
- Authors
- Abdou, E. M., Kandil, S. M., & Miniawy, H. M. F. E.
- Affiliations
- National Organization for Drug Control and Research (EG)
- Modern University for Information and Technology (EG)
- Cairo University (EG)
- Corresponding author
- Abdou, Ebtsam M.
- Venue
- International Journal of Pharmaceutics
- Publisher
- Elsevier BV
- Published
- 2017-08
- Volume
- 529
- Issue
- 1-2
- Pages
- 667-677
- ISSN
- 0378-5173 (ISSN-L)
- OpenAlex
- W2735486104
- Cited by
- 124
- References
- 74
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 17 · 2023: 12 · 2022: 18 · 2021: 15 · 2020: 17 · 2019: 18 · 2018: 4
- FWCI
- 5.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Pharmaceutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- zolmitriptan, migraine, intranasal drug delivery, chitosan, nasal mucosa permeation, brain targeting, pharmacokinetics, residence time, globule size, zeta potential, acute migraine treatment
- MeSH terms
- Administration, Intranasal, Animals, Brain, Chemistry, Pharmaceutical, Migraine Disorders, Nasal Mucosa, Tryptamines, Oxazolidinones, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review